Langham Ronald Leroy JR has filed 12 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 7092 shares of Enhabit, Inc. ($EHAB) on March 06, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2025 | Enhabit, Inc. | $EHAB | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | A | Common Stock | 7092 | $8.02 | 58,541.0000 | 50,200,000 | 13.78% | 0.01% |
| March 6, 2025 | Enhabit, Inc. | $EHAB | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | F | Common Stock | 2377 | $8.02 | 56,164.0000 | 50,200,000 | 4.06% | 0.00% |
| March 1, 2025 | Enhabit, Inc. | $EHAB | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | F | Common Stock | 3041 | $8.37 | 51,449.0000 | 50,200,000 | 5.58% | 0.01% |
| Feb. 25, 2025 | Enhabit, Inc. | $EHAB | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | F | Common Stock | 334 | $8.26 | 54,490.0000 | 50,200,000 | 0.61% | 0.00% |
| Jan. 1, 2025 | Enhabit, Inc. | $EHAB | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | F | Common Stock | 1031 | $7.81 | 55,480.0000 | 50,200,000 | 1.82% | 0.00% |
| Jan. 1, 2025 | Enhabit, Inc. | $EHAB | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | F | Common Stock | 656 | $7.81 | 54,824.0000 | 50,200,000 | 1.18% | 0.00% |
| July 1, 2024 | Enhabit, Inc. | $EHAB | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | F | Common Stock | 673 | $8.75 | 56,491.0000 | 49,900,000 | 1.18% | 0.00% |
| March 1, 2024 | Enhabit, Inc. | $EHAB | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | A | Common Stock | 15027 | $8.81 | 57,798.0000 | 49,900,000 | 35.13% | 0.03% |
| March 1, 2024 | Enhabit, Inc. | $EHAB | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | S | Common Stock | 634 | $8.81 | 57,164.0000 | 49,900,000 | 1.10% | 0.00% |
| Feb. 24, 2024 | Enhabit, Inc. | $EHAB | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | F | Common Stock | 181 | $9.49 | 43,104.0000 | 49,900,000 | 0.42% | 0.00% |
| Feb. 25, 2024 | Enhabit, Inc. | $EHAB | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | F | Common Stock | 333 | $9.49 | 42,771.0000 | 49,900,000 | 0.77% | 0.00% |
| Jan. 1, 2024 | Enhabit, Inc. | $EHAB | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | F | Common Stock | 1043 | $10.35 | 43,285.0000 | 49,900,000 | 2.35% | 0.00% |